SCIBAC INC.
Milpitas, CA · Founded 2015 · CIK 0001648437 · Biotech · Private
Live biotherapeutic microbes engineered via DRIVE platform to treat cystic fibrosis-associated nontuberculous mycobacterial lung infections
scibac.com →- Grants
- $573K
- 2 awards
- Sector median: 1
- Raised
- —
- 1 Form D · Jul 2015
- 135 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 7
- 1 granted · 6 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Live biotherapeutics for the treatment of nontuberculous mycobacteria lung infection associated with cystic fibrosis | $286,530 | |
| Federal grant | Department of Health and Human Services · Phase I · Live biotherapeutics for the treatment of nontuberculous mycobacteria lung infection associated with cystic fibrosis | $286,530 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1792 | Green Growth Brands Inc. | — | $17M |
| 1793 | PMed Holdings, LLC | — | $1.6M |
| 1794 | Mekanistic Therapeutics, LLC | — | — |
| 1795 | SCIBAC INC. | — | — |
| 1796 | NATSAR PHARMACEUTICALS, INC. | — | $4.2M |
| 1797 | vTv Therapeutics Holdings LLC | — | — |
| 1798 | Arbor Plastic Technologies, LLC | — | $910K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Anthony CannDirector · Executive Officer · Promoter
- Lawrence FryDirector · Executive Officer · Promoter
- Jeanette MuchaDirector · Executive Officer · Promoter
- Derik TwomeyDirector · Promoter
Patents
- Live Biotherapeutics to Treat and Prevent Lung Conditionsapplication
- Method for Producing Chimeric Microbial Hybridsapplication
- Method for Producing Chimeric Microbial Hybridsapplication
- Method for Producing Chimeric Microbial Hybridsgranted
- Live Biotherapeutics to Treat and Prevent Lung Conditionsapplication
- Live Biotherapeutics To Treat And Prevent Lung Conditionsapplication
- A Method For Producing Chimeric Microbial Hybridsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.